Astromelanin

Astromelanin
The Soviet microbiologist Valentina P. Lyakh developed the drug AstroMelanin in 1969, based on the results of the development, a thesis “Melanopigment of the Antarctic black yeast Nadsoniellanigravar. hesuelica and its physiological function "(Moscow, 1970) was written by her. open

Scientific work on the preparation has been carried out for over 15 years and consists of more than 30,000 pages.

Studies of the substance were carried out by the largest scientists in the field of oncology in Russia and the USA, South Korea and Japan.

About AstroMelanin open

AstroMelanin received approving reviews and support from the heads of three oncological centers in Russia, which rated it as a promising drug that reflects the latest methods in the treatment of tumor diseases.

The work was carried out by a team of famous Russian scientists oncologists under the leadership of the Director of the Russian Oncological Center named after N.N. Blokhin RAMS Academician N.N. Trapeznikov and Director of the Research Institute of Experimental Diagnostics and Therapy of Tumors of the Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences, Doctor of Medical Sciences, Professor, Academician of the RMTA A. Y. Baryshnikov. 

Letter to the first President of the Russian Federation signed by the best oncologists of the Russian Federation open

AstroMelanin awards open

The significance of the development was assessed by the UN Institute in Tokyo open

Medical Center of the Administrative Department of the President of the Russian Federation open

Research conducted by a world-renowned Doctor, Dr. Van Hoff, Head of the Institute for Drug Development and Cancer Therapy in San Antonio, Texas, USA, showed that when exposed for six days, AstroMelanin COMPLETELY inhibits the growth of human breast cancer cells open
AstroMelanin is non-toxic and does not cause side effects on other organs and systems of the body. The technology is environmentally friendly.

UFG documents open